Alembic Pharma rating – Hold: India sales bright spot of Q3FY21
Execution key for India and US sales; FY21-22e EPS up 3%; valuations factor in prospects; ‘Hold’ retained
Trending News
- Getting Financial Freedom with Online Trading
- Gaining Financial Freedom with Amazon
- Gain Financial Freedom – Make Money with Facebook (2021 Guide)
- Gain Financial Freedom – Make Money with eCommerce (2021 Guide)
- Gain Financial Freedom – Make Money with Shopify
- Gain Financial Freedom – Make Money with Bitcoin Investing
- Gain Financial Freedom – Make Money with Review Sites
- Gain Financial Freedom – Make Money with Bitcoin Cash Trading
- Gain Financial Freedom with Forex Trading
- Gain Financial Freedom with CFD Trading